M K Proteins Ltd Hits Upper Circuit Amid Strong Buying Pressure Despite Recent Downtrend

3 hours ago
share
Share Via
M K Proteins Ltd, a micro-cap player in the edible oil sector, witnessed a remarkable trading session on 4 Mar 2026 as it hit its upper circuit price limit, reflecting intense buying interest despite recent bearish trends. The stock’s surge comes amid a backdrop of sectoral weakness and regulatory trading freezes, underscoring a complex market dynamic for investors.
M K Proteins Ltd Hits Upper Circuit Amid Strong Buying Pressure Despite Recent Downtrend

Stock Performance and Price Action

On 4 Mar 2026, M K Proteins Ltd (Stock ID: 1002751) recorded a high price of ₹5.79, reaching the maximum permissible daily price band of ₹0.20, signalling an upper circuit hit. The last traded price (LTP) settled at ₹4.79, with the stock showing a marginal decline of -0.83% on the day. Despite this, the upper circuit event indicates strong demand and buying pressure that pushed the stock to its daily price ceiling during intraday trading.

The stock’s trading volume was robust, with a total traded volume of approximately 3.49 lakh shares and a turnover of ₹0.165 crore. This volume reflects heightened investor participation, especially notable given the stock’s micro-cap status and relatively modest market capitalisation of ₹179.80 crore.

Contextualising Recent Trends

It is important to note that M K Proteins has been under pressure in recent sessions, with a consecutive three-day decline resulting in a cumulative loss of -6.08%. The stock hit a new 52-week and all-time low of ₹4.50 on the same day it touched the upper circuit, highlighting significant intraday volatility. This volatility is further accentuated by the stock trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a bearish technical setup.

Sector-wise, the edible oil segment, particularly the solvent extraction sub-sector, has been weak, with the sector index falling by -4.39% on the day. M K Proteins outperformed its sector by 3.6%, a notable relative strength amid broader sectoral declines. The Sensex also declined by -2.01%, indicating a generally cautious market environment.

Investor Participation and Liquidity

Investor interest in M K Proteins has shown signs of revival, with delivery volumes on 2 Mar 2026 rising by 130.56% to 2.57 lakh shares compared to the five-day average. This surge in delivery volume suggests that investors are increasingly willing to hold the stock, reflecting confidence in its medium-term prospects despite recent price weakness.

Liquidity remains adequate for trading, with the stock’s turnover representing about 2% of its five-day average traded value, allowing for reasonable trade sizes without excessive market impact.

Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!

  • - New profitability achieved
  • - Growth momentum building
  • - Under-the-radar entry

Get In Before Others →

Regulatory Freeze and Unfilled Demand

The upper circuit hit triggered a regulatory freeze on further buying for the remainder of the trading session, a mechanism designed to curb excessive volatility and speculative trading. This freeze often results in unfilled demand, as buyers remain eager to accumulate shares but are unable to transact beyond the price band limit.

Such unfilled demand can create a strong base for subsequent sessions, potentially leading to further price appreciation if buying interest sustains. However, it also introduces uncertainty, as the stock’s ability to maintain momentum depends on broader market conditions and sectoral developments.

Fundamental and Market Sentiment Analysis

M K Proteins currently holds a Mojo Score of 46.0, categorised as a Sell rating, a slight improvement from its previous Strong Sell grade assigned on 24 Nov 2025. The upgrade reflects some stabilisation in fundamentals or market perception, but the overall sentiment remains cautious.

The company’s micro-cap status and modest market capitalisation of ₹179.80 crore place it in a high-risk, high-volatility category, often subject to sharp price swings driven by liquidity and speculative flows rather than fundamental shifts.

Investors should also consider the stock’s relative underperformance against broader benchmarks and its position below all major moving averages, which typically signal a downtrend. The recent outperformance relative to the edible oil sector on the day of the upper circuit is encouraging but requires confirmation through sustained price and volume action.

M K Proteins Ltd or something better? Our SwitchER feature analyzes this micro-cap Edible Oil stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Outlook and Investor Considerations

For investors considering M K Proteins Ltd, the recent upper circuit event signals renewed interest and potential short-term momentum. However, the stock’s technical weakness, micro-cap risks, and sectoral headwinds warrant a cautious approach.

Given the regulatory freeze and unfilled demand, the immediate sessions will be critical in determining whether the stock can sustain its gains or revert to its downward trajectory. Monitoring delivery volumes, price action relative to moving averages, and sectoral trends will be essential for informed decision-making.

Investors should weigh the stock’s current Sell rating and modest Mojo Score against their risk appetite and investment horizon. Diversification and consideration of fundamentally stronger alternatives within the edible oil sector or broader market may be prudent.

Summary

M K Proteins Ltd’s upper circuit hit on 4 Mar 2026 highlights a day of strong buying pressure amid a challenging market environment. The stock’s intraday high of ₹5.79 and increased delivery volumes indicate investor interest despite recent losses and technical weakness. Regulatory trading freezes have created unfilled demand, setting the stage for potential follow-through in coming sessions. While the stock’s micro-cap status and Sell rating advise caution, the event underscores the dynamic nature of small-cap trading in India’s edible oil sector.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is M K Proteins Ltd falling/rising?
Mar 03 2026 01:20 AM IST
share
Share Via
M K Proteins Ltd is Rated Sell by MarketsMOJO
Feb 28 2026 10:10 AM IST
share
Share Via
M K Proteins Ltd is Rated Sell by MarketsMOJO
Feb 17 2026 10:10 AM IST
share
Share Via
When is the next results date for M K Proteins Ltd?
Feb 06 2026 11:19 PM IST
share
Share Via
M K Proteins Ltd is Rated Sell by MarketsMOJO
Feb 06 2026 10:11 AM IST
share
Share Via
M K Proteins Ltd is Rated Sell
Jan 26 2026 10:10 AM IST
share
Share Via
M K Proteins Ltd Stock Falls to 52-Week Low of Rs.5.11
Jan 19 2026 04:06 PM IST
share
Share Via